About Ramucirumab
            
            Class: | Monoclonal antibody (VEGF receptor antagonist)  
Use: | Treatment of advanced gastric or gastroesophageal junction adenocarcinoma, non-small cell lung cancer (NSCLC), and metastatic colorectal cancer in combination with other therapies  
Adult dose: | 8 mg/kg IV every 2 weeks for gastric cancer; 10 mg/kg IV every 2 weeks for NSCLC; 8 mg/kg IV every 2 weeks for colorectal cancer  
Pediatric dose: | Safety and efficacy not established in pediatric patients  
Side effects: | Hypertension, 
         
        
            
                
                
                    
                        Drug Class
                    
                    Monoclonal antibody (VEGF receptor antagonist)
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of advanced gastric or gastroesophageal junction adenocarcinoma, non-small cell lung cancer (NSCLC), and metastatic colorectal cancer in combination with other therapies
                 
                
                
                    
                        Storage Requirements
                    
                    Store at 2°C to 8°C (36°F to 46°F); do not freeze; protect from light
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Eli Lilly & Co Inc., U.S.A
                    
                    
                    Package Size
                    10ml Glass Vial
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 4295.50
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        8 mg/kg IV every 2 weeks for gastric cancer; 10 mg/kg IV every 2 weeks for NSCLC; 8 mg/kg IV every 2 weeks for colorectal cancer
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients
                    
                 
                
                
                    
                        Side Effects
                    
                    Hypertension, diarrhea, fatigue, nausea, decreased appetite, abdominal pain, headache, and infusion-related reactions
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Hypersensitivity to ramucirumab or any component of the formulation; severe uncontrolled hypertension
         
        
        
            
                Important Warnings
            
            Risk of severe bleeding, gastrointestinal perforation, and impaired wound healing; monitor blood pressure regularly; caution in patients with a history of thromboembolic events
         
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.